InsidersTradesSigma
Follow the 海森药业 share price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 海森药业 has recorded 1 public disclosures. Market capitalisation: €2.6bn. The latest transaction was disclosed on 30 December 2025 (Sale). Among the most active insiders: 胡康康. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
海森药业 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative pharmaceutical products.